Chest X-Ray Tomosynthesis for Lung Cancer Screening
This observational study is looking at a new imaging device called Chest X-ray Tomosynthesis (CXRT) to see if it can be an alternative to standard CT scans for finding lung cancer. Researchers want to know how accurate CXRT is at detecting lung cancer in people who are getting screened or have a suspicious lung nodule. They also plan to develop artificial intelligence (AI) tools to help read these CXRT images. You might be able to join if you are between 30 and 85 years old, are undergoing lung cancer screening, are being evaluated for a suspicious lung nodule, or have been newly diagnosed with lung cancer. The study will compare CXRT images to CT scans to see how well they identify lung cancer, with results expected by the end of 2026.
- Study design
- This is an observational study aiming to enroll 1000 participants. It compares a new imaging method to standard CT scans.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoint, detection of lung cancer, will be measured through December 31, 2026.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Next Generation Chest X-Ray Tomosynthesis for Screening of Lung Cancer
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Albert Hsiao, MD PhD · PRINCIPAL_INVESTIGATOR · UC San Diego, Department of Radiology
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Chest X-ray tomosynthesis detection of lung cancerthrough 12/31/2026
Diagnostic accuracy of chest tomosynthesis in identifying biopsy-proven lung cancer